Piver 1977.
Methods | Randomized, double blind, placebo controlled | |
Participants | n=148 FIGO stage IIB or IIIB ca cx (41 previously reported in Piver 1974) | |
Interventions | RT ‐ 50Gy EBRT in 2Gy fractions over 5 wks followed by 23‐40Gy brachytherapy to point A for stage 2b 60Gy in 2Gy fractions over 6 wks or in 8wks with 2wks rest mid way followed by 25Gy brachytherapy to points A for stage 3b | |
Outcomes | Acute chemotherapy toxicity NED rate | |
Notes | No details of randomization or allocation concealment | |
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Allocation concealment? | Unclear risk | B ‐ Unclear |